WormserGP, ShapiroED. Implications of gender in chronic Lyme disease. J Womens Health, 2009; 18:831–834.
2.
Centers for Disease Control and Prevention (CDC). Lyme disease—2008 case definition. www.cdc.gov/ncphi/disss/nndss/casedef/lyme_disease_2008.htm. 2009 June 19.
3.
BaconRM, KugelerKJ, MeadPS. Centers for Disease Control, Prevention (CDC). Surveillance for Lyme disease—United States, 1992–2006. MMWR Surveill Summary, 2008; 57:1–9.
4.
FederHMJr, GerberMA, LugerSW, RyanRW. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis, 1992; 15:788–793.
5.
SheplerLT. Sex bias in Lyme diagnosis. Posted on Avon website June 13, 2000. http://www.centuryinter.net/tjs11/bug/15.htm. 2009 September 23.
6.
Centers for Disease Control and Prevention (CDC). Lyme disease—United States, 2001–2002. MMWR, 2004; 53:365–369.
EngstromSM, ShoopE, JohnsonRC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol, 1995; 33:419–427.
9.
MaB, ChristenB, LeungD, Vigo-PelfreyC. Serodiagnosis of Lyme borreliosis by Western immunoblot: Reactivity of various significant antibodies against Borrelia burgdorferi. J Clin Microbiol, 1992; 30:370–376.
10.
BennetL, BerglundJ. Reinfection with Lyme borreliosis: a retrospective follow-up study in southern Sweden. Scand J Infect Dis, 2002; 34:183–186.
11.
JareforsS, BennetL, YouEet al.Lyme borreliosis reinfection: might it be explained by a gender difference in immune response?Immunology, 2006; 118:224–232.
12.
BennetL, StjernbergL, BerglundJ. Effect of gender on clinical and epidemiologic features of Lyme borreliosis. Vector Borne Zoonotic Dis, 2007; 7:34–41.
13.
StrickerRB, WingerEE. Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol Lett, 2001; 76:43–48.
14.
ShoemakerRC, GiclasPC, CrowderC, HouseD, GlovskyMM. Complement split products C3a and C4a are early markers of acute Lyme disease in tick bite patients in the United States. Int Arch Allergy Immunol, 2008; 146:255–261.
15.
StrickerRB, SavelyVR, MotanyaNC, GiclasPC. Complement split products C3a and C4a in chronic Lyme disease. Scand J Immunol, 2009; 69:64–69.
16.
JohnsonL, StrickerRB. Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process. J Med Ethics, 2009; 35:283–288.
